India's pharmaceutical regulatory framework has undergone significant transformation in recent years, with the Central Drugs Standard Control Organisation (CDSCO) and the Pharmacovigilance Programme of India (PvPI) playing increasingly active roles…
India's Central Drugs Standard Control Organisation (CDSCO) has flagged approximately 280 drug batches as Not of Standard Quality (NSQ) in its latest quality surveillance sweep, according to reports in The…
On May 21, 2026, India's Central Drugs Standard Control Organisation (CDSCO) issued a clear directive: no injectable product can be classified or sold as a cosmetic. The directive, reported by…
The Central Drugs Standard Control Organisation (CDSCO) has waived the requirement for local Phase 3 clinical trials for generic versions of lenacapavir, a breakthrough HIV prevention drug, moving India significantly…